Pediatrix Medical Group (MD) to Release Earnings on Tuesday

Pediatrix Medical Group (NYSE:MD) is anticipated to issue its Q1 2025 quarterly earnings data before the market opens on Tuesday, May 6th. Analysts expect Pediatrix Medical Group to post earnings of $0.25 per share and revenue of $451.44 million for the quarter.

Pediatrix Medical Group (NYSE:MD) last issued its quarterly earnings results on Thursday, February 20th. The company reported $0.49 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.37 by $0.12. Pediatrix Medical Group had a positive return on equity of 15.47% and a negative net margin of 4.92%. The firm had revenue of $502.36 million during the quarter, compared to analyst estimates of $486.22 million. On average, analysts expect Pediatrix Medical Group to post $1 EPS for the current fiscal year and $1 EPS for the next fiscal year.

Pediatrix Medical Group Price Performance

Shares of Pediatrix Medical Group stock opened at $12.36 on Tuesday. The stock has a market cap of $1.06 billion, a PE ratio of -10.30, a price-to-earnings-growth ratio of 1.74 and a beta of 1.32. Pediatrix Medical Group has a 52 week low of $6.62 and a 52 week high of $17.67. The company has a current ratio of 1.60, a quick ratio of 1.42 and a debt-to-equity ratio of 0.81. The company’s 50-day moving average price is $14.01 and its two-hundred day moving average price is $13.99.

Analysts Set New Price Targets

A number of research analysts have commented on the company. Truist Financial lowered their target price on Pediatrix Medical Group from $18.00 to $16.00 and set a “hold” rating on the stock in a research note on Friday, April 11th. UBS Group increased their target price on Pediatrix Medical Group from $16.50 to $18.50 and gave the company a “neutral” rating in a research note on Friday, February 21st. Finally, StockNews.com upgraded shares of Pediatrix Medical Group from a “hold” rating to a “buy” rating in a research note on Wednesday, January 22nd. Four investment analysts have rated the stock with a hold rating and three have assigned a buy rating to the stock. According to MarketBeat, the stock presently has an average rating of “Hold” and a consensus target price of $16.75.

About Pediatrix Medical Group

Pediatrix Medical Group, Inc, together with its subsidiaries, provides newborn, maternal-fetal, pediatric cardiology, and other pediatric subspecialty care services in the United States. It offers neonatal care services, such as clinical care to babies born prematurely or with complications within specific units at hospitals through neonatal physician subspecialists, neonatal nurse practitioners, and other pediatric clinicians.